company background image
600062 logo

China Resources Double-Crane PharmaceuticalLtd SHSE:600062 Stock Report

Last Price

CN¥17.42

Market Cap

CN¥17.8b

7D

-4.7%

1Y

4.2%

Updated

16 Jul, 2024

Data

Company Financials +

China Resources Double-Crane Pharmaceutical Co.,Ltd.

SHSE:600062 Stock Report

Market Cap: CN¥17.8b

China Resources Double-Crane Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China Resources Double-Crane PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥17.42
52 Week HighCN¥24.13
52 Week LowCN¥14.80
Beta0.064
11 Month Change-18.48%
3 Month Change-15.11%
1 Year Change4.19%
33 Year Change52.94%
5 Year Change38.47%
Change since IPO511.93%

Recent News & Updates

We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

Jul 16
We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

Recent updates

We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

Jul 16
We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 24
China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

Mar 02
Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

Shareholder Returns

600062CN PharmaceuticalsCN Market
7D-4.7%1.1%2.2%
1Y4.2%-16.2%-18.6%

Return vs Industry: 600062 exceeded the CN Pharmaceuticals industry which returned -16.2% over the past year.

Return vs Market: 600062 exceeded the CN Market which returned -18.6% over the past year.

Price Volatility

Is 600062's price volatile compared to industry and market?
600062 volatility
600062 Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.5%
10% most volatile stocks in CN Market9.8%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 600062's share price has been volatile over the past 3 months.

Volatility Over Time: 600062's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193912,269n/awww.dcpc.com

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other.

China Resources Double-Crane Pharmaceutical Co.,Ltd. Fundamentals Summary

How do China Resources Double-Crane PharmaceuticalLtd's earnings and revenue compare to its market cap?
600062 fundamental statistics
Market capCN¥17.79b
Earnings (TTM)CN¥1.37b
Revenue (TTM)CN¥10.28b

12.9x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600062 income statement (TTM)
RevenueCN¥10.28b
Cost of RevenueCN¥4.60b
Gross ProfitCN¥5.68b
Other ExpensesCN¥4.31b
EarningsCN¥1.37b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 23, 2024

Earnings per share (EPS)1.35
Gross Margin55.24%
Net Profit Margin13.36%
Debt/Equity Ratio2.1%

How did 600062 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

19%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.